The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.
The technology is intended for U.S. service members but expected to be used widely by civilians.
The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.
The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.
Building Disaster Resilience Through Collaboration
Tampa General Hospital Acquires 53-Acre Property in Citrus Hills
Community Health Systems to Sell 3 Pennsylvania Hospitals to Tenor Health Foundation
A 'Superbug' Is on the Rise in Hospitals
The Next Generation of Security Tech in Healthcare Facilities